GI262570, a tyrosine-based PPARγ agonist, reduces triglycerides and increases HDL-C concentrations in patients with type 2 diabetes mellitus when combined with glibenclamide treatment
Lata Kler, Robert C. Edwards, Simon J. McNeil, Patrick RoundVolume:
50
Year:
2000
Language:
english
DOI:
10.1016/s0168-8227(00)81593-4
File:
PDF, 207 KB
english, 2000